RecruitingNCT07071831

RETRO Study (RETrograde Renal Access Outcomes)

RetroPerc®-A Prospective, Multi-institutional Trial of Efficacy of the RetroPerc Device


Sponsor

University of Kansas Medical Center

Enrollment

150 participants

Start Date

Dec 6, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to learn about the benefit of using RetroPerc® in obtaining renal access for percutaneous nephrolithotomy. The device is already used in routine clinical practice by urologists around the country. Participants who are already scheduled to undergo percutaneous nephrolithotomy as part of their regular care will be asked to participate.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called RetroPerc® for people with renal stones. The study is currently recruiting participants at 2 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERetroPerc®

The RetroPerc® will be used to obtain renal access.


Locations(2)

University of South Florida

Tampa, Florida, United States

University of Kansas Medical Center

Kansas City, Kansas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07071831


Related Trials